116 related articles for article (PubMed ID: 6811784)
1. Effects of thyrotropin releasing hormone on cerebellar mutant mice--a kinesiological comparison between rolling mouse Nagoya, weaver and reeler.
Muroga T; Adachi K; Konagaya M; Takayanagi T; Sobue I
Jpn J Med; 1982 Apr; 21(2):101-8. PubMed ID: 6811784
[TBL] [Abstract][Full Text] [Related]
2. Studies on thyrotropin releasing hormone in cerebellar ataxia mutant mouse brain.
Fukuma N; Nihei N
Life Sci; 1986 May; 38(18):1625-31. PubMed ID: 2871469
[TBL] [Abstract][Full Text] [Related]
3. Alterations in local cerebral glucose metabolism and endogenous thyrotropin-releasing hormone levels in rolling mouse Nagoya and effect of thyrotropin-releasing hormone tartrate.
Nakayama T; Nagai Y
Jpn J Pharmacol; 1996 Nov; 72(3):241-6. PubMed ID: 8957685
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological effect of thyrotropin-releasing hormone on ataxic mutant mice.
Mano Y; Matsui K; Toyoshima E; Ando K
Acta Neurol Scand; 1986 Apr; 73(4):352-8. PubMed ID: 3088901
[TBL] [Abstract][Full Text] [Related]
5. Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy.
Nakamura T; Honda M; Kimura S; Tanabe M; Oda S; Ono H
Biol Pharm Bull; 2005 Dec; 28(12):2244-7. PubMed ID: 16327158
[TBL] [Abstract][Full Text] [Related]
6. Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.
Kinoshita K; Watanabe Y; Asai H; Yamamura M; Matsuoka Y
Br J Pharmacol; 1995 Dec; 116(8):3274-8. PubMed ID: 8719807
[TBL] [Abstract][Full Text] [Related]
7. [Automatic recording and analysis of the ambulatory dynamics of cerebellar ataxic mice-rolling mouse Nagoya, Reeler and Weaver (author's transl)].
Toyoshima E; Maruhashi H; Matsui K; Mano Y; Ando K
Jikken Dobutsu; 1981 Apr; 30(2):129-35. PubMed ID: 7286066
[TBL] [Abstract][Full Text] [Related]
8. [Changes in movement and ataxic gait with development in genetically ataxic mice: a comparison with the level of cerebellar cyclic nucleotide].
Matsui K; Kato N; Ando K
Jikken Dobutsu; 1988 Jan; 37(1):1-6. PubMed ID: 3366183
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic regulation of the spinal cord content of thyrotropin releasing hormone in the cerebellar ataxia mutant mouse.
Endo S; Itoh M; Serizawa O
J Neurol Sci; 1993 Sep; 118(2):194-201. PubMed ID: 8229069
[TBL] [Abstract][Full Text] [Related]
10. [The antiataxic mechanism of TRH in rolling mouse Nagoya: the effects of pretreatment with dopaminergic and cholinergic drugs].
Matsui K; Ando K
Jikken Dobutsu; 1984 Oct; 33(4):465-9. PubMed ID: 6440800
[TBL] [Abstract][Full Text] [Related]
11. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
Kinoshita K; Fujitsuka T; Yamamura M; Matsuoka Y
Eur J Pharmacol; 1995 Feb; 274(1-3):65-72. PubMed ID: 7768282
[TBL] [Abstract][Full Text] [Related]
12. Central noradrenaline metabolism in cerebellar ataxic mice.
Muramoto O; Ando K; Kanazawa I
Brain Res; 1982 Apr; 237(2):387-95. PubMed ID: 6123371
[TBL] [Abstract][Full Text] [Related]
13. Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies.
Kinoshita K; Fukushima T; Kodama Y; Sugihara J; Yamamura M; Matsuoka Y
Biol Pharm Bull; 1997 Jan; 20(1):36-9. PubMed ID: 9013803
[TBL] [Abstract][Full Text] [Related]
14. [Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
Matsui K; Toyoshima E; Mano U; Ando K
Yakubutsu Seishin Kodo; 1982 Dec; 2(2):77-80. PubMed ID: 6821292
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-releasing hormone (TRH) in the cerebellum.
Shibusawa N; Hashimoto K; Yamada M
Cerebellum; 2008; 7(1):84-95. PubMed ID: 18418668
[TBL] [Abstract][Full Text] [Related]
16. Distribution and characterization of the TRH receptors in the CNS of ataxic mutant mouse.
Yamaguchi T; Hayashi K; Murakami H; Maruyama S; Yamaguchi M
Neurochem Res; 1984 Apr; 9(4):477-84. PubMed ID: 6087174
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the behavioral pharmacology of TRH-T in cytosine arabinoside-induced ataxic mice: a comparison with genetically ataxic mice].
Matsui K; Mano Y; Mukoyama M; Muramoto O; Toyoshima E; Ando K
Jikken Dobutsu; 1983 Jan; 32(1):13-9. PubMed ID: 6406242
[TBL] [Abstract][Full Text] [Related]
18. [Effect of DN-1417 on ataxia in Rolling mouse Nagoya and Staggerer mouse in comparison with the effect of TRH].
Matsui K; Mano Y; Ando K
Yakubutsu Seishin Kodo; 1986 Jun; 6(2):281-3. PubMed ID: 3096012
[TBL] [Abstract][Full Text] [Related]
19. Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice.
Matsui K; Wada K; Kwak S
Eur J Pharmacol; 1994 Mar; 254(3):295-7. PubMed ID: 8013566
[TBL] [Abstract][Full Text] [Related]
20. Neurotransmitter abnormality in Rolling mouse Nagoya, an ataxic mutant mouse.
Muramoto O; Kanazawa I; Ando K
Brain Res; 1981 Jun; 215(1-2):295-304. PubMed ID: 6167317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
